Incubation with the non-selective adenosine receptor agonist NECA leads to up-regulation of expression of RGS2 mRNA and down-regulation of RGS3 in astrocytes (Fig 3A and 3B), similar to its effects in astrocytoma cells. The gene discussed is RGS2; the disease is astrocytoma (excluding glioblastoma).